XML 213 R184.htm IDEA: XBRL DOCUMENT v3.22.4
Information Provided in Connection with Investments in Deferred Annuity Contracts and Signature Notes Issued or Assumed by John Hancock Life Insurance Company (U.S.A.) - Consolidated Statement of Cash Flows (Detail) - CAD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Operating activities    
Net income (loss) $ 7,182 $ 6,912
Adjustments:    
Equity in net income of unconsolidated subsidiaries 0  
Increase (decrease) in insurance contract liabilities (33,413) 10,719
Increase (decrease) in investment contract liabilities 41 44
(Increase) decrease in reinsurance assets excluding coinsurance transactions 159 754
Amortization of (premium) discount on invested assets (32) 181
Other amortization 538 529
Net realized and unrealized (gains) losses and impairment on assets 47,270 4,824
Gain on U.S. variable annuity reinsurance transaction (pre-tax) (1,070)  
Gain on derecognition of Joint Venture interest during Manulife TEDA acquisition (pre-tax) (95)  
Deferred income tax expense (recovery) 731 (127)
Stock option expense 5 9
Cash provided by operating activities before undernoted items 21,316 23,845
Dividends from unconsolidated subsidiary 0  
Cash decrease due to U.S. variable annuity reinsurance transaction (1,377)  
Changes in policy related and operating receivables and payables (2,204) (690)
Cash provided by (used in) operating activities 17,735 23,155
Investing activities    
Purchases and mortgage advances (111,768) (120,965)
Disposals and repayments 93,407 96,728
Changes in investment broker net receivables and payables (67) (186)
Net cash increase (decrease) from sale (purchase) of subsidiary (182) (19)
Cash provided by (used in) investing activities (18,610) (24,442)
Financing activities    
Issue of long-term debt, net 946  
Redemption of long-term debt   (1,250)
Redemption of capital instruments (1,000) (818)
Secured borrowings 437 26
Change in repurchase agreements and securities sold but not yet purchased (551) 186
Changes in deposits from Bank clients, net 1,703 (164)
Lease payments (120) (124)
Shareholders' dividends and other equity distributions (2,787) (2,500)
Common shares repurchased (1,884)  
Common shares issued, net 23 51
Preferred shares and other equity issued, net 990 3,171
Preferred shares redeemed, net (711) (612)
Contributions from (distributions to) non-controlling interests, net (51) (13)
Cash provided by (used in) financing activities (3,005) (2,047)
Increase (decrease) during the year (3,880) (3,334)
Effect of foreign exchange rate changes on cash and short-term securities 585 (319)
Net cash and short-term securities, January 1 21,930 25,583
Net cash and short-term securities, December 31 18,635 21,930
Cash and short-term securities    
Gross cash and short-term securities, beginning of year 22,594 26,167
Net payments in transit, included in other liabilities, beginning of year (664) (584)
Net cash and short-term securities, January 1 21,930 25,583
Gross cash and short-term securities, end of year 19,153 22,594
Net payments in transit, included in other liabilities, end of year (518) (664)
Net cash and short-term securities, December 31 18,635 21,930
Supplemental disclosures on cash flow information:    
Interest received 12,133 11,376
Interest paid 1,248 981
Income taxes paid 1,238 571
MFC (Guarantor) [Member]    
Operating activities    
Net income (loss) 7,294 7,105
Adjustments:    
Equity in net income of unconsolidated subsidiaries (7,226) (6,972)
Other amortization 9 16
Net realized and unrealized (gains) losses and impairment on assets (36) 62
Deferred income tax expense (recovery) (33) 34
Cash provided by operating activities before undernoted items 8 245
Dividends from unconsolidated subsidiary 6,200 5,000
Changes in policy related and operating receivables and payables 45 (22)
Cash provided by (used in) operating activities 6,253 5,223
Investing activities    
Disposals and repayments 1  
Investment in common shares of subsidiaries (2,479) (3,700)
Notes receivable from subsidiaries 46 (13)
Cash provided by (used in) investing activities (2,432) (3,713)
Financing activities    
Issue of long-term debt, net 946  
Redemption of long-term debt   (1,250)
Redemption of capital instruments   (468)
Shareholders' dividends and other equity distributions (2,787) (2,500)
Common shares repurchased (1,884)  
Common shares issued, net 23 51
Preferred shares and other equity issued, net 990 3,171
Preferred shares redeemed, net (711) (612)
Notes payable to subsidiaries (415) 129
Cash provided by (used in) financing activities (3,838) (1,479)
Increase (decrease) during the year (17) 31
Effect of foreign exchange rate changes on cash and short-term securities 2  
Net cash and short-term securities, January 1 78 47
Net cash and short-term securities, December 31 63 78
Cash and short-term securities    
Gross cash and short-term securities, beginning of year 78 47
Net cash and short-term securities, January 1 78 47
Gross cash and short-term securities, end of year 63 78
Net cash and short-term securities, December 31 63 78
Supplemental disclosures on cash flow information:    
Interest received 512 499
Interest paid 424 396
JHUSA (Issuer) [Member]    
Operating activities    
Net income (loss) 2,046 1,552
Adjustments:    
Equity in net income of unconsolidated subsidiaries (997) (1,218)
Increase (decrease) in insurance contract liabilities (20,032) (562)
Increase (decrease) in investment contract liabilities 44 50
(Increase) decrease in reinsurance assets excluding coinsurance transactions 6,869 1,544
Amortization of (premium) discount on invested assets 46 57
Other amortization 125 124
Net realized and unrealized (gains) losses and impairment on assets 15,150 1,533
Gain on U.S. variable annuity reinsurance transaction (pre-tax) (1,026)  
Deferred income tax expense (recovery) 294 190
Stock option expense (3) (2)
Cash provided by operating activities before undernoted items 2,516 3,268
Dividends from unconsolidated subsidiary 399 489
Cash decrease due to U.S. variable annuity reinsurance transaction (1,263)  
Changes in policy related and operating receivables and payables 2,805 424
Cash provided by (used in) operating activities 4,457 4,181
Investing activities    
Purchases and mortgage advances (28,798) (31,746)
Disposals and repayments 23,505 27,194
Changes in investment broker net receivables and payables (11) (202)
Capital contribution to unconsolidated subsidiaries (1) (1)
Return of capital from unconsolidated subsidiaries 19 1
Notes receivable from subsidiaries (7)  
Cash provided by (used in) investing activities (5,293) (4,754)
Financing activities    
Lease payments (5) (7)
Dividends paid to parent (734) (742)
Cash provided by (used in) financing activities (739) (749)
Increase (decrease) during the year (1,575) (1,322)
Effect of foreign exchange rate changes on cash and short-term securities 225 (20)
Net cash and short-term securities, January 1 3,565 4,907
Net cash and short-term securities, December 31 2,215 3,565
Cash and short-term securities    
Gross cash and short-term securities, beginning of year 4,087 5,213
Net payments in transit, included in other liabilities, beginning of year (522) (306)
Net cash and short-term securities, January 1 3,565 4,907
Gross cash and short-term securities, end of year 2,614 4,087
Net payments in transit, included in other liabilities, end of year (399) (522)
Net cash and short-term securities, December 31 2,215 3,565
Supplemental disclosures on cash flow information:    
Interest received 4,050 4,112
Interest paid 118 73
Income taxes paid 124 (118)
Other subsidiaries    
Operating activities    
Net income (loss) 8,111 7,997
Adjustments:    
Equity in net income of unconsolidated subsidiaries (2,046) (1,552)
Increase (decrease) in insurance contract liabilities (13,381) 11,281
Increase (decrease) in investment contract liabilities (3) (6)
(Increase) decrease in reinsurance assets excluding coinsurance transactions (6,710) (790)
Amortization of (premium) discount on invested assets (78) 124
Other amortization 404 389
Net realized and unrealized (gains) losses and impairment on assets 32,156 3,229
Gain on U.S. variable annuity reinsurance transaction (pre-tax) (44)  
Gain on derecognition of Joint Venture interest during Manulife TEDA acquisition (pre-tax) (95)  
Deferred income tax expense (recovery) 470 (351)
Stock option expense 8 11
Cash provided by operating activities before undernoted items 18,792 20,332
Dividends from unconsolidated subsidiary 734 742
Cash decrease due to U.S. variable annuity reinsurance transaction (114)  
Changes in policy related and operating receivables and payables (5,054) (1,092)
Cash provided by (used in) operating activities 14,358 19,982
Investing activities    
Purchases and mortgage advances (82,970) (89,219)
Disposals and repayments 69,901 69,534
Changes in investment broker net receivables and payables (56) 16
Net cash increase (decrease) from sale (purchase) of subsidiary (182) (19)
Notes receivable from parent 415 (129)
Cash provided by (used in) investing activities (12,892) (19,817)
Financing activities    
Redemption of capital instruments (1,000) (350)
Secured borrowings 437 26
Change in repurchase agreements and securities sold but not yet purchased (551) 186
Changes in deposits from Bank clients, net 1,703 (164)
Lease payments (115) (117)
Common shares issued, net 2,479 3,700
Contributions from (distributions to) non-controlling interests, net (51) (13)
Dividends paid to parent (6,599) (5,489)
Capital contributions by parent 1 1
Return of capital to parent (19) (1)
Notes payable to parent (39) 13
Cash provided by (used in) financing activities (3,754) (2,208)
Increase (decrease) during the year (2,288) (2,043)
Effect of foreign exchange rate changes on cash and short-term securities 358 (299)
Net cash and short-term securities, January 1 18,287 20,629
Net cash and short-term securities, December 31 16,357 18,287
Cash and short-term securities    
Gross cash and short-term securities, beginning of year 18,429 20,907
Net payments in transit, included in other liabilities, beginning of year (142) (278)
Net cash and short-term securities, January 1 18,287 20,629
Gross cash and short-term securities, end of year 16,476 18,429
Net payments in transit, included in other liabilities, end of year (119) (142)
Net cash and short-term securities, December 31 16,357 18,287
Supplemental disclosures on cash flow information:    
Interest received 8,732 7,847
Interest paid 1,867 1,594
Income taxes paid 1,114 689
Consolidation adjustments [Member]    
Operating activities    
Net income (loss) (10,269) (9,742)
Adjustments:    
Equity in net income of unconsolidated subsidiaries 10,269 9,742
Dividends from unconsolidated subsidiary (7,333) (6,231)
Cash provided by (used in) operating activities (7,333) (6,231)
Investing activities    
Investment in common shares of subsidiaries 2,479 3,700
Capital contribution to unconsolidated subsidiaries 1 1
Return of capital from unconsolidated subsidiaries (19) (1)
Notes receivable from parent (415) 129
Notes receivable from subsidiaries (39) 13
Cash provided by (used in) investing activities 2,007 3,842
Financing activities    
Common shares issued, net (2,479) (3,700)
Dividends paid to parent 7,333 6,231
Capital contributions by parent (1) (1)
Return of capital to parent 19 1
Notes payable to parent 39 (13)
Notes payable to subsidiaries 415 (129)
Cash provided by (used in) financing activities 5,326 2,389
Supplemental disclosures on cash flow information:    
Interest received (1,161) (1,082)
Interest paid $ (1,161) $ (1,082)